A prominent Food and Drug Administration researcher sharply criticized a safety study by the manufacturer of the diabetes drug Avandia on Tuesday as an FDA panel weighed whether to yank the drug from the market.
A decade after critics first accused the Food and Drug Administration of downplaying side effects from Avandia, the agency says it will reveal on Friday the data it is reviewing ahead of an advisory panel meeting about the safety of the popular diabetes drug.
Should people who don't have high cholesterol take a cholesterol-lowering statin? Maybe, according to the U.S. Food and Drug Administration, which is considering an advisory panel's recent recommendation to do just that.
Taking a low-dose aspirin every day can help prevent heart attacks in people who've already had one. But if you've never had a heart attack (or stroke), the risks of taking a daily low-dose aspirin outweigh the benefits, according to a U.K. report published in Drug and Therapeutics Bulletin.
Healthy men and women with good cholesterol levels could significantly reduce their risk of heart disease by taking cholesterol-lowering drugs, better known as statins, according to a study released at the American Heart Association meetings in November.
An extremely potent experimental cholesterol drug being developed by Eli Lilly and Co. failed to show an advantage over an existing treatment sold by Abbott Laboratories Inc. in a clinical trial that could determine the fate of the medicine.